Timothy Harrison

3.6k total citations
45 papers, 1.5k citations indexed

About

Timothy Harrison is a scholar working on Physiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Timothy Harrison has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Physiology, 12 papers in Pharmacology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Timothy Harrison's work include Asthma and respiratory diseases (15 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Timothy Harrison is often cited by papers focused on Asthma and respiratory diseases (15 papers), Alzheimer's disease research and treatments (13 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Timothy Harrison collaborates with scholars based in United Kingdom, United States and Singapore. Timothy Harrison's co-authors include Mark S. Shearman, Alan Nadin, Richard Hubbard, Tricia M. McKeever, Dominick Shaw, Jonathan D.J. Wrigley, Dirk Beher, Huw D. Lewis, José L. Castro and Anne E. Tattersfield and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Timothy Harrison

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Harrison United Kingdom	23	790	399	329	322	212	45	1.5k
A. Buntinx Belgium	14	207 0.3×	176 0.4×	57 0.2×	234 0.7×	357 1.7×	23	1.0k
Marie A. Holahan United States	22	121 0.2×	76 0.2×	173 0.5×	278 0.9×	68 0.3×	50	1.1k
Kerryn McCluskie United States	18	320 0.4×	221 0.6×	49 0.1×	325 1.0×	50 0.2×	23	964
Eugene Chang United States	26	141 0.2×	165 0.4×	104 0.3×	788 2.4×	97 0.5×	50	1.8k
Hui Xiao China	14	417 0.5×	61 0.2×	56 0.2×	370 1.1×	75 0.4×	42	1.3k
Mario Bigioni Italy	25	301 0.4×	82 0.2×	259 0.8×	796 2.5×	77 0.4×	58	1.8k
Ramesh Boinpally United States	19	179 0.2×	207 0.5×	51 0.2×	219 0.7×	87 0.4×	86	1.2k
Shanshan Cui China	19	127 0.2×	102 0.3×	104 0.3×	506 1.6×	48 0.2×	49	1.1k
C. S. McFarlane Canada	14	288 0.4×	100 0.3×	98 0.3×	199 0.6×	135 0.6×	20	619
Moureq R. Alotaibi Saudi Arabia	23	351 0.4×	113 0.3×	70 0.2×	621 1.9×	85 0.4×	74	1.6k

Countries citing papers authored by Timothy Harrison

Since Specialization

Citations

This map shows the geographic impact of Timothy Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Harrison more than expected).

Fields of papers citing papers by Timothy Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Harrison. The network helps show where Timothy Harrison may publish in the future.

Co-authorship network of co-authors of Timothy Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Harrison. A scholar is included among the top collaborators of Timothy Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Harrison. Timothy Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stevenson, Leanne, Xiaodun Li, Sriganesh Jammula, et al.. (2024). Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinoma. Scientific Reports. 14(1). 32121–32121.

Aguilar‐Raab, Corina, Marco Warth, Markus Moessner, et al.. (2023). A compassion-based treatment for couples with the female partner suffering from current depressive disorder: A randomized-controlled trial. Journal of Affective Disorders. 342. 127–138. 4 indexed citations

Menzies‐Gow, Andrew, Mark Gurnell, Liam G. Heaney, et al.. (2022). Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study. European Respiratory Journal. 60(6). 2103226–2103226. 11 indexed citations

Menzies‐Gow, Andrew, Mark Gurnell, Liam G. Heaney, et al.. (2021). Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. The Lancet Respiratory Medicine. 10(1). 47–58. 90 indexed citations

Clements, Debbie, David J. Jackson, Charlotte K. Billington, et al.. (2017). Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity. American Journal of Respiratory and Critical Care Medicine. 195(8). 1000–1009. 52 indexed citations

Negm, Ola H., Noor Kalsheker, Nichola Gale, et al.. (2017). Autoantibodies of IgM and IgG classes show differences in recognition of multiple autoantigens in chronic obstructive pulmonary disease. Clinical Immunology. 183. 344–353. 9 indexed citations

Todd, Ian, Patrick J. Tighe, Michelle John, et al.. (2016). Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease. Mediators of Inflammation. 2016. 1–9. 28 indexed citations

Robinson, Paul M., et al.. (2012). Changing Transfusion Practice in Total Hip Arthroplasty: Observational Study of the Reduction of Blood Use Over 6 Years. Orthopedics. 35(11). e1586–91. 7 indexed citations

Jones, Henry Wynn, et al.. (2011). Revision of medial Oxford unicompartmental knee replacement to a total knee replacement: Similar to a primary?. The Knee. 19(4). 339–343. 51 indexed citations

10.

Sovani, Milind, Janet Oborne, Sue Cooper, et al.. (2007). Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?. British Journal of General Practice. 58(546). 37–43. 59 indexed citations

11.

Jelley, Richard A., Jason Elliott, Karl R. Gibson, et al.. (2006). 3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity. Bioorganic & Medicinal Chemistry Letters. 16(14). 3839–3842. 14 indexed citations

12.

Best, Jonathan D., David W. Smith, Michael Reilly, et al.. (2006). The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse. Journal of Pharmacology and Experimental Therapeutics. 320(2). 552–558. 64 indexed citations

13.

Shaw, Duncan, Jonathan D. Best, Alan Nadin, et al.. (2006). 3,4-Fused cyclohexyl sulfones as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 3073–3077. 22 indexed citations

14.

Clarke, Earl E., Ian Churcher, Jonathan D.J. Wrigley, et al.. (2006). Intra- or Intercomplex Binding to the γ-Secretase Enzyme. Journal of Biological Chemistry. 281(42). 31279–31289. 30 indexed citations

15.

Harrison, Timothy & Dirk Beher. (2003). γ-Secretase Inhibitors – from Molecular Probes to New Therapeutics?. Progress in medicinal chemistry. 41. 99–127. 4 indexed citations

16.

Lewis, Sarah, Conroy Wong, Sue Cooper, et al.. (2002). The Impact of Oral Corticosteroid Use on Bone Mineral Density and Vertebral Fracture. American Journal of Respiratory and Critical Care Medicine. 166(5). 691–695. 91 indexed citations

17.

Xu, Min, Ming‐Tain Lai, Qian Huang, et al.. (2002). γ-Secretase: characterization and implication for Alzheimer disease therapy. Neurobiology of Aging. 23(6). 1023–1030. 25 indexed citations

18.

Harrison, Timothy. (2001). Systemic Availability of Inhaled Budesonide and Fluticasone Propionate. BioDrugs. 15(6). 405–411. 11 indexed citations

19.

Beher, Dirk, Jonathan D.J. Wrigley, Alan Nadin, et al.. (2001). Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase Inhibitor. Journal of Biological Chemistry. 276(48). 45394–45402. 74 indexed citations

20.

Harrison, Timothy, et al.. (2000). New drugs in asthma.. PubMed. 33(5). 425–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact